139 related articles for article (PubMed ID: 8839880)
21. Hemoglobin Sabine [beta 91 (F7) Leu-->Pro]: occurrence in a Sardinian individual with hemolytic anemia and inclusion bodies.
Gasperini D; Galanello R; Melis MA; Iannelli S; Giordano P; Bernini LF; Cao A
Haematologica; 1992; 77(5):381-3. PubMed ID: 1336469
[TBL] [Abstract][Full Text] [Related]
22. Regression of extramedullary haemopoiesis and augmentation of fetal haemoglobin concentration during hydroxyurea therapy in beta thalassaemia.
Saxon BR; Rees D; Olivieri NF
Br J Haematol; 1998 Jun; 101(3):416-9. PubMed ID: 9633880
[TBL] [Abstract][Full Text] [Related]
23. KLF10 gene expression is associated with high fetal hemoglobin levels and with response to hydroxyurea treatment in β-hemoglobinopathy patients.
Borg J; Phylactides M; Bartsakoulia M; Tafrali C; Lederer C; Felice AE; Papachatzopoulou A; Kourakli A; Stavrou EF; Christou S; Hou J; Karkabouna S; Lappa-Manakou C; Ozgur Z; van Ijcken W; von Lindern M; Grosveld FG; Georgitsi M; Kleanthous M; Philipsen S; Patrinos GP
Pharmacogenomics; 2012 Oct; 13(13):1487-500. PubMed ID: 23057549
[TBL] [Abstract][Full Text] [Related]
24. Pharmacologic induction of fetal hemoglobin synthesis: cellular and molecular mechanisms.
Yang YM; Pace B
Pediatr Pathol Mol Med; 2001; 20(1):87-106. PubMed ID: 12673846
[TBL] [Abstract][Full Text] [Related]
25. Priapism following splenectomy in an unstable hemoglobin: hemoglobin Olmsted beta 141 (H19) Leu-->Arg.
Thuret I; Bardakdjian J; Badens C; Wajcman H; Galacteros F; Vanuxem D; Perrimond H; Giraud F; Lena-Russo D
Am J Hematol; 1996 Feb; 51(2):133-6. PubMed ID: 8579053
[TBL] [Abstract][Full Text] [Related]
26. [New treatments of hemoglobinopathies].
de Montalembert M
Presse Med; 1997 Jun; 26(20):972-6. PubMed ID: 9238187
[No Abstract] [Full Text] [Related]
27. Hydroxyurea as a first-line treatment of extramedullary hematopoiesis in patients with beta thalassemia: Four case reports.
Karimi M; Cohan N; Pishdad P
Hematology; 2015 Jan; 20(1):53-7. PubMed ID: 24717020
[TBL] [Abstract][Full Text] [Related]
28. Two patients in a family with unstable hemoglobin, Hb Hirosaki: anemia was ameliorated but hemolysis persists after splenectomy.
Shinohara K; Hattori Y
Int J Hematol; 2006 Aug; 84(2):186-7. PubMed ID: 16926144
[No Abstract] [Full Text] [Related]
29. Hemoglobin Southampton complicated by cerebral ischemia, moyamoya, and hydroxyurea-induced methemoglobinemia.
Boucher AA; Gurunathan A; Taylor JM; Ricci KW; Vadivelu S; Quinn CT
Am J Hematol; 2019 Aug; 94(8):949-954. PubMed ID: 31095774
[No Abstract] [Full Text] [Related]
30. Increasing fetal hemoglobin in sickle cell disease: comparisons of 5-azacytidine (subcutaneous or oral) with hydroxyurea.
Dover GJ; Charache S; Boyer SH
Trans Assoc Am Physicians; 1984; 97():140-5. PubMed ID: 6085527
[No Abstract] [Full Text] [Related]
31. Unstable oxygen delivery.
Desforges JF
N Engl J Med; 1973 May; 288(18):965-6. PubMed ID: 4693250
[No Abstract] [Full Text] [Related]
32. Partial glutathione reductase deficiency as a cause of diverse clinical manifestations in a family with unstable hemoglobin (Hemoglobin Haná, β63(E7) His-Asn).
Mojzikova R; Dolezel P; Pavlicek J; Mlejnek P; Pospisilova D; Divoky V
Blood Cells Mol Dis; 2010 Oct; 45(3):219-22. PubMed ID: 20692194
[TBL] [Abstract][Full Text] [Related]
33. The pharmacological manipulation of fetal haemoglobin: trials using hydroxyurea and recombinant human erythropoietin.
el-Hazmi MA; al-Momen A; Warsy AS; Kandaswamy S; Huraib S; Harakati M; al-Mohareb F
Acta Haematol; 1995; 93(2-4):57-61. PubMed ID: 7543719
[TBL] [Abstract][Full Text] [Related]
34. Histone deacetylase inhibitor FK228 is a potent inducer of human fetal hemoglobin.
Cao H; Stamatoyannopoulos G
Am J Hematol; 2006 Dec; 81(12):981-3. PubMed ID: 16888791
[TBL] [Abstract][Full Text] [Related]
35. Extramedullary hematopoiesis-related pleural effusion: the case of beta-thalassemia.
Aessopos A; Tassiopoulos S; Farmakis D; Moyssakis I; Kati M; Polonifi K; Tsironi M
Ann Thorac Surg; 2006 Jun; 81(6):2037-43. PubMed ID: 16731126
[TBL] [Abstract][Full Text] [Related]
36. Globin gene studies create a puzzle.
Kolata G
Science; 1984 Feb; 223(4635):470-1. PubMed ID: 6197757
[No Abstract] [Full Text] [Related]
37. Influence of hydroxyurea on fetal hemoglobin production in vitro.
Miller BA; Platt O; Hope S; Dover G; Nathan DG
Blood; 1987 Dec; 70(6):1824-9. PubMed ID: 2445401
[TBL] [Abstract][Full Text] [Related]
38. Mutant fetal hemoglobin causing cyanosis in a newborn.
Priest JR; Watterson J; Jones RT; Faassen AE; Hedlund BE
Pediatrics; 1989 May; 83(5):734-6. PubMed ID: 2470017
[TBL] [Abstract][Full Text] [Related]
39. Genomic variants in members of the Krüppel-like factor gene family are associated with disease severity and hydroxyurea treatment efficacy in β-hemoglobinopathies patients.
Stratopoulos A; Kolliopoulou A; Karamperis K; John A; Kydonopoulou K; Esftathiou G; Sgourou A; Kourakli A; Vlachaki E; Chalkia P; Theodoridou S; Papadakis MN; Gerou S; Symeonidis A; Katsila T; Ali BR; Papachatzopoulou A; Patrinos GP
Pharmacogenomics; 2019 Jul; 20(11):791-801. PubMed ID: 31393228
[No Abstract] [Full Text] [Related]
40. Pharmacogenomics and therapeutics of hemoglobinopathies.
Patrinos GP; Grosveld FG
Hemoglobin; 2008; 32(1-2):229-36. PubMed ID: 18275000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
